AZD3632
/ AstraZeneca
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
February 18, 2026
D8620C00001: A trial to learn how safe AZD3632 is, how well it works, and how it moves throughout the body over time in adults with acute leukemia and myelodysplastic syndrome with HOX gene overexpression
(clinicaltrialsregister.eu)
- P1/2 | N=17 | Recruiting | Sponsor: AstraZeneca AB
Monotherapy • New P1/2 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology • CDX2 • CREBBP • ETV6 • KMT2A • NPM1 • NUP214 • NUP98 • RUNX1
January 30, 2026
MOMENTUM: Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
(clinicaltrials.gov)
- P1/2 | N=84 | Recruiting | Sponsor: AstraZeneca | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Monotherapy • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology • KMT2A
November 29, 2025
MOMENTUM: Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
(clinicaltrials.gov)
- P1/2 | N=84 | Not yet recruiting | Sponsor: AstraZeneca | Trial completion date: Jun 2029 ➔ Feb 2029 | Trial primary completion date: Jun 2029 ➔ Feb 2029
Monotherapy • Trial completion date • Trial primary completion date • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology
September 04, 2025
MOMENTUM: Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
(clinicaltrials.gov)
- P1/2 | N=84 | Not yet recruiting | Sponsor: AstraZeneca
Monotherapy • New P1/2 trial • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology
1 to 4
Of
4
Go to page
1